Mauna Kea Technologies Announces Strong Presence at Asia-Pacific Digestive Week / World Congress of Gastroenterology 2013
Published: Sep 19, 2013
Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced a strong presence at the joint Asia-Pacific Digestive Week / World Congress of Gastroenterology (APDW/WCOG) 2013. 13 presentations will highlight the use of Optical Biopsy across many of the most pervasive diseases in the gastrointestinal tract.
Help employers find you! Check out all the jobs and post your resume.